Literature DB >> 15797228

Selective portal vein clamping for radiofrequency ablation of hepatocellular carcinoma with portal vein invasion.

Kenneth S Chok1, Kenneth C Ng, Chi Ming Lam, Kelvin K Ng, Ronnie T Poon, Sheung Tat Fan.   

Abstract

Surgical resection provides potential cure for patients with hepatocellular carcinoma. Unfortunately, resection is suitable in only about 10-37% of patients because of the limited hepatic functional reserve from the underlying chronic liver disease in the majority of patients. Survival of patients with unresectable diseases, especially those with portal vein tumor invasion, remains very poor. Radiofrequency ablation (RFA) is a form of locoregional therapy that allows a selected group of previously inoperable patients to be treated. However, problems with RFA leading to induced portal vein thrombosis have been reported in the literature. Nevertheless, patients with portal vein tumor invasion may be considered for radiofrequency tumor ablation to improve survival. We report the case of a patient with hepatocellular carcinoma with left portal vein invasion. Complete tumor ablation was achieved after RFA with left portal vein clamping. He remained disease free both radiologically and biochemically 6 months after the operation.

Entities:  

Mesh:

Year:  2005        PMID: 15797228     DOI: 10.1016/j.gassur.2004.09.056

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  23 in total

1.  Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.

Authors:  N Nicoli; A Casaril; L Marchiori; G Mangiante; G Marini; R Colombari; A Portuese; A R Hasheminia
Journal:  Chir Ital       Date:  2000 Jan-Feb

2.  Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein.

Authors:  J Fan; Z Q Wu; Z Y Tang; J Zhou; S J Qiu; Z C Ma; X D Zhou; S L Ye
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Authors:  J M Llovet; J Bustamante; A Castells; R Vilana; M del C Ayuso; M Sala; C Brú; J Rodés; J Bruix
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

4.  Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results.

Authors:  L Buscarini; E Buscarini; M Di Stasi; D Vallisa; P Quaretti; A Rocca
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

5.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

6.  Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model.

Authors:  S B Chinn; F T Lee; G D Kennedy; C Chinn; C D Johnson; T C Winter; T F Warner; D M Mahvi
Journal:  AJR Am J Roentgenol       Date:  2001-03       Impact factor: 3.959

7.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

8.  Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.

Authors:  T F Wood; D M Rose; M Chung; D P Allegra; L J Foshag; A J Bilchik
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

9.  Hepatic radiofrequency ablation.

Authors:  David A Iannitti; Damian E Dupuy; William W Mayo-Smith; Brian Murphy
Journal:  Arch Surg       Date:  2002-04

10.  Lesion progression with time and the effect of vascular occlusion following radiofrequency ablation of the liver.

Authors:  W J Wiersinga; M C Jansen; I H Straatsburg; P H Davids; J M Klaase; D J Gouma; T M van Gulik
Journal:  Br J Surg       Date:  2003-03       Impact factor: 6.939

View more
  1 in total

Review 1.  Thyroid Radiofrequency Ablation: Updates on Innovative Devices and Techniques.

Authors:  Hye Sun Park; Jung Hwan Baek; Auh Whan Park; Sae Rom Chung; Young Jun Choi; Jeong Hyun Lee
Journal:  Korean J Radiol       Date:  2017-05-19       Impact factor: 3.500

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.